• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型mRNA衰变抑制剂可消除病理生理细胞转变。

A novel mRNA decay inhibitor abolishes pathophysiological cellular transition.

作者信息

Kami Daisuke, Ishizaki Toshimasa, Taya Toshihiko, Katoh Akira, Kouji Hiroyuki, Gojo Satoshi

机构信息

Department of Regenerative Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Department of Pharmacology, Faculty of Medicine, Oita University, Oita, Japan.

出版信息

Cell Death Discov. 2022 Jun 7;8(1):278. doi: 10.1038/s41420-022-01076-4.

DOI:10.1038/s41420-022-01076-4
PMID:35672286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9174231/
Abstract

In cells, mRNA synthesis and decay are influenced by each other, and their balance is altered by either external or internal cues, resulting in changes in cell dynamics. We previously reported that it is important that an array of mRNAs that shape a phenotype are degraded before cellular transitions, such as cellular reprogramming and differentiation. In adipogenesis, the interaction between DDX6 and 4E-T had a definitive impact on the pathway in the processing body (PB). We screened a library of α-helix analogs with an alkaloid-like backbone to identify compounds that inhibit the binding between DDX6 and 4E-T proteins, which occurs between the α-helix of structured and internally disordered proteins. IAMC-00192 was identified as a lead compound. This compound directly inhibited the interaction between DDX6 and 4E-T. IAMC-00192 inhibited the temporal increase in PB formation that occurs during adipogenesis and epithelial-mesenchymal transition (EMT) and significantly suppressed these cellular transitions. In the EMT model, the half-life of preexisting mRNAs in PBs was extended twofold by the compound. The novel inhibitor of RNA decay not only represents a potentially useful tool to analyze in detail the pathological conditions affected by RNA decay and how it regulates the pathological state. The identification of this inhibitor may lead to the discovery of a first-in-class RNA decay inhibitor drug.

摘要

在细胞中,mRNA的合成与降解相互影响,其平衡会因外部或内部信号而改变,从而导致细胞动态变化。我们之前报道过,在细胞转变(如细胞重编程和分化)之前,一系列塑造表型的mRNA降解很重要。在脂肪生成过程中,DDX6与4E-T之间的相互作用对加工体(PB)中的信号通路有决定性影响。我们筛选了一个具有生物碱样骨架的α-螺旋类似物文库,以鉴定抑制DDX6与4E-T蛋白之间结合的化合物,这种结合发生在结构化和内在无序蛋白的α-螺旋之间。IAMC-00192被鉴定为先导化合物。该化合物直接抑制DDX6与4E-T之间的相互作用。IAMC-00192抑制脂肪生成和上皮-间质转化(EMT)过程中PB形成的时间性增加,并显著抑制这些细胞转变。在EMT模型中,该化合物使PB中现有mRNA的半衰期延长了两倍。这种新型RNA降解抑制剂不仅是详细分析受RNA降解影响的病理状况及其如何调节病理状态的潜在有用工具。这种抑制剂的鉴定可能会导致发现一类首创的RNA降解抑制剂药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/8476bab57b46/41420_2022_1076_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/51fbd25bce82/41420_2022_1076_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/091c9f9b35a3/41420_2022_1076_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/26aef9f0a16d/41420_2022_1076_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/87c46c7171a5/41420_2022_1076_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/963befc26936/41420_2022_1076_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/8476bab57b46/41420_2022_1076_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/51fbd25bce82/41420_2022_1076_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/091c9f9b35a3/41420_2022_1076_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/26aef9f0a16d/41420_2022_1076_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/87c46c7171a5/41420_2022_1076_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/963befc26936/41420_2022_1076_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8783/9174231/8476bab57b46/41420_2022_1076_Fig6_HTML.jpg

相似文献

1
A novel mRNA decay inhibitor abolishes pathophysiological cellular transition.一种新型mRNA衰变抑制剂可消除病理生理细胞转变。
Cell Death Discov. 2022 Jun 7;8(1):278. doi: 10.1038/s41420-022-01076-4.
2
RNA decay in processing bodies is indispensable for adipogenesis.细胞质体中的 RNA 降解对于脂肪生成是必不可少的。
Cell Death Dis. 2021 Mar 17;12(4):285. doi: 10.1038/s41419-021-03537-7.
3
The DEAD-box RNA-binding protein DDX6 regulates parental RNA decay for cellular reprogramming to pluripotency.DEAD-box RNA 结合蛋白 DDX6 调控亲本 RNA 降解以实现细胞重编程为多能性。
PLoS One. 2018 Oct 1;13(10):e0203708. doi: 10.1371/journal.pone.0203708. eCollection 2018.
4
The eIF4E-Binding Protein 4E-T Is a Component of the mRNA Decay Machinery that Bridges the 5' and 3' Termini of Target mRNAs.真核生物翻译起始因子4E结合蛋白4E-T是mRNA降解机制的一个组成部分,它连接靶标mRNA的5'和3'末端。
Cell Rep. 2015 Jun 9;11(9):1425-36. doi: 10.1016/j.celrep.2015.04.065. Epub 2015 May 28.
5
A role for the eIF4E-binding protein 4E-T in P-body formation and mRNA decay.真核生物翻译起始因子4E结合蛋白4E-T在P小体形成和mRNA降解中的作用。
J Cell Biol. 2005 Sep 12;170(6):913-24. doi: 10.1083/jcb.200504039.
6
4E-T-bound mRNAs are stored in a silenced and deadenylated form.4E-T 结合的 mRNAs 以沉默和去腺苷酸化的形式储存。
Genes Dev. 2020 Jun 1;34(11-12):847-860. doi: 10.1101/gad.336073.119. Epub 2020 Apr 30.
7
Phosphorylation of the eukaryotic translation initiation factor 4E-transporter (4E-T) by c-Jun N-terminal kinase promotes stress-dependent P-body assembly.真核翻译起始因子 4E 转运蛋白(4E-T)的磷酸化由 c-Jun N 端激酶(c-Jun N-terminal kinase)促进应激依赖的 P 体组装。
Mol Cell Biol. 2012 Nov;32(22):4572-84. doi: 10.1128/MCB.00544-12. Epub 2012 Sep 10.
8
IP6K1 upregulates the formation of processing bodies by influencing protein-protein interactions on the mRNA cap.IP6K1 通过影响 mRNA 帽上的蛋白质-蛋白质相互作用而上调加工体的形成。
J Cell Sci. 2021 Dec 15;134(24). doi: 10.1242/jcs.259117. Epub 2021 Dec 16.
9
Structure of a Human 4E-T/DDX6/CNOT1 Complex Reveals the Different Interplay of DDX6-Binding Proteins with the CCR4-NOT Complex.人源4E-T/DDX6/CNOT1复合物的结构揭示了DDX6结合蛋白与CCR4-NOT复合物的不同相互作用。
Cell Rep. 2015 Oct 27;13(4):703-711. doi: 10.1016/j.celrep.2015.09.033. Epub 2015 Oct 17.
10
High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.MDCK细胞上皮-间质转化的高通量mRNA和miRNA分析
BMC Genomics. 2015 Nov 16;16:944. doi: 10.1186/s12864-015-2036-9.

引用本文的文献

1
Fluorescence-activated particle sorting for condensate purification.用于凝聚物纯化的荧光激活粒子分选
Nat Protoc. 2025 Jul 18. doi: 10.1038/s41596-025-01216-x.
2
Peptide-encoding gene transfer to modulate intracellular protein-protein interactions.用于调节细胞内蛋白质-蛋白质相互作用的肽编码基因转移。
Mol Ther Methods Clin Dev. 2024 Feb 28;32(2):101226. doi: 10.1016/j.omtm.2024.101226. eCollection 2024 Jun 13.

本文引用的文献

1
mRNA Stability Assay Using transcription inhibition by Actinomycin D in Mouse Pluripotent Stem Cells.使用放线菌素D抑制转录在小鼠多能干细胞中进行mRNA稳定性测定
Bio Protoc. 2018 Nov 5;8(21):e3072. doi: 10.21769/BioProtoc.3072.
2
RNA decay in processing bodies is indispensable for adipogenesis.细胞质体中的 RNA 降解对于脂肪生成是必不可少的。
Cell Death Dis. 2021 Mar 17;12(4):285. doi: 10.1038/s41419-021-03537-7.
3
Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators.在通向有效蛋白质-蛋白质相互作用调节剂的道路上,非肽 α-螺旋类似物的进化。
Eur J Med Chem. 2021 Feb 5;211:113015. doi: 10.1016/j.ejmech.2020.113015. Epub 2020 Nov 12.
4
Design and synthesis of 14 and 15-membered macrocyclic scaffolds exhibiting inhibitory activities of hypoxia-inducible factor 1α.设计和合成具有抑制缺氧诱导因子 1α 活性的 14 和 15 元大环支架。
Bioorg Med Chem. 2021 Jan 15;30:115949. doi: 10.1016/j.bmc.2020.115949. Epub 2020 Dec 13.
5
Determination of Binding Kinetics of Intrinsically Disordered Proteins by Surface Plasmon Resonance.利用表面等离子体共振测定内源性无序蛋白质的结合动力学。
Methods Mol Biol. 2020;2141:611-627. doi: 10.1007/978-1-0716-0524-0_31.
6
Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy.致心律失常性心肌病:发病机制、促心律失常重构及新的危险分层和治疗方法。
Cardiovasc Res. 2020 Jul 15;116(9):1571-1584. doi: 10.1093/cvr/cvaa084.
7
A Comprehensive Review on Current Advances in Peptide Drug Development and Design.关于肽类药物研发与设计的最新进展的全面综述。
Int J Mol Sci. 2019 May 14;20(10):2383. doi: 10.3390/ijms20102383.
8
High-Quality Data of Protein/Peptide Interaction by Isothermal Titration Calorimetry.等温滴定量热法测定蛋白质/肽相互作用的高质量数据
Methods Mol Biol. 2019;1964:99-117. doi: 10.1007/978-1-4939-9179-2_8.
9
Clinical candidates modulating protein-protein interactions: The fragment-based experience.临床候选药物调节蛋白质-蛋白质相互作用:基于片段的经验。
Eur J Med Chem. 2019 Apr 1;167:76-95. doi: 10.1016/j.ejmech.2019.01.084. Epub 2019 Feb 5.
10
EMT Transition States during Tumor Progression and Metastasis.肿瘤进展和转移过程中的 EMT 过渡态。
Trends Cell Biol. 2019 Mar;29(3):212-226. doi: 10.1016/j.tcb.2018.12.001. Epub 2018 Dec 26.